Quazolast
Quazolast (RHC 3988) is a orally active mast cell stabilizer. Quazolast also is a potent mediator release inhibitor. Quazolast reduces the gastric damage. Quazolast has the potential for the research of gastric ulcers.
For research use only. We do not sell to patients.
- CAS No.: 86048-40-0
- Formula: C12H7ClN2O3
- Molecular Weight:262.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Quazolast (3.1, 6.3, 12.5, 25 mg/kg; p.o.) reduces the gastric damage associated with 0.6 N HC1 administration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:150 g Male Sprague Dawley rat[1]
-
Dosage:0.2, 1, 5 mg/kg
-
Administration:P.o.
-
Result:Decreased the rat gastric mucosa damage in a dose dependent manner and reduced the gastric ulcer index (68%) at 5 mg/kg in rat induced by absolute ethanol (0.9 mg/kg).
Chemical Information
-
CAS No. 86048-40-0
-
Molecular Weight 262.65
-
Formula C12H7ClN2O3
-
SMILES
COC(C1=NC2=CC(Cl)=C3C(N=CC=C3)=C2O1)=O
-
Synonyms
RHC 3988
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Fitzpatrick LR, et al. Gastroprotective and ulcer healing profile of the mast cell stabilizer quazolast in rats. Agents Actions. 1991 Jul;33(3-4):330-6. [Content Brief]
[2]. Dave NK, et al. A controlled, double-blind study of the effect of quazolast on nasal challenge with ragweed antigen. Ann Allergy. 1990 Oct;65(4):298-302. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)